Another shortcoming of our study was that our clinical material did not comprise mRNA, and therefore LRIG1 mRNA expression analysis could not be performed to clarify its potential role as a prognostic factor in breast cancer. This evidence concerns the gene LRIG1 and breast carcinoma.